-transparent.png){kind=logo}
Glutathione S-transferase pi gene methylation has recently been described in prostatic adenocarcinoma. Aggregate data on 115 samples studied to date have found an 87% sensitivity and 92% specificity for prostate cancer diagnosis. The current literature about this new marker is herein summarized, and possible molecular mechanisms by which glutathione S-transferase pi may participate in prostatic carcinogenesis are reviewed. The possible clinical implications of this molecular alteration in the diagnosis of prostatic adenocarcinoma are also studied.
Related Publications
R E Jimenez, and
A H Fischer, and
J A Petros, and
M B Amin
November 1994,
Proceedings of the National Academy of Sciences of the United States of America,
R E Jimenez, and
A H Fischer, and
J A Petros, and
M B Amin
November 2003,
Molecular and cellular biochemistry,
R E Jimenez, and
A H Fischer, and
J A Petros, and
M B Amin
March 1990,
Clinical chemistry,
R E Jimenez, and
A H Fischer, and
J A Petros, and
M B Amin
February 1999,
Oncogene,
R E Jimenez, and
A H Fischer, and
J A Petros, and
M B Amin
January 1989,
Cancer,
R E Jimenez, and
A H Fischer, and
J A Petros, and
M B Amin
October 1988,
The Biochemical journal,
R E Jimenez, and
A H Fischer, and
J A Petros, and
M B Amin
January 1989,
Gene,
R E Jimenez, and
A H Fischer, and
J A Petros, and
M B Amin
September 2007,
Human pathology,
R E Jimenez, and
A H Fischer, and
J A Petros, and
M B Amin
June 1991,
International journal of peptide and protein research,
R E Jimenez, and
A H Fischer, and
J A Petros, and
M B Amin
December 2012,
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland,
